New COVID Antivirals Do Not Replace the Need to Vaccinate
With the advent of new COVID drugs comes the fear that people will opt out of vaccination altogether
With the advent of new COVID drugs comes the fear that people will opt out of vaccination altogether
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
A new delivery method for certain vaccines could make the lifesaving treatments more effective and accessible
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
An immunologist explains how the immune system changes as people mature
The FDA’s decision to expand eligibility for the Pfizer vaccine to young kids could mean less illness, safer school and more freedom
The pandemic has brought the nursing profession into crisis; the solution is in the public’s hands
Fluvoxamine is both inexpensive and highly effective at preventing mild COVID-19 from turning severe
This Covid question played out long ago, in the fight against smallpox in 1872
As U.S. Food and Drug Administration advisers recommend authorizing shots for children aged five to 11, researchers predict what this might mean for populations
A new book reveals how quiet scientists, big drug companies and the Trump administration raced to meet the COVID threat—and why kids are just now being considered for shots
Companies are updating vaccines and testing them on people to prepare for whatever comes next in the pandemic
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
Now that the FDA has authorized the shots for a broad range of Americans, many people want to know if they need a booster dose. Here’s what we have learned so far
The WHO-approved RTS,S vaccine has a modest efficacy and requires a complex regimen of doses, so ample funding and clear communication are crucial to success
Studies show the vaccines against the disease not only can be safely given to people who are expecting but can also save lives
The number of pregnant people suffering from severe COVID is preventable tragedy
The actual number who resign rather than get the vaccine is much smaller than the survey data suggest
Pfizer expects to have safety and efficacy data on five- to 11-year-olds by the end of the month, but federal authorities must still review it
Standard remedies offer little relief for the itchy rash caused by the plant, but researchers have found promising clues in the immune system
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account